pharmaceutical investing Mesoblast Licensee Files for Marketing Approval to Treat Epidermolysis Bullosa
Hercules Capital Provides US$15M From Existing Facility for Mesoblast to Accelerate Product Commercialization Programs
Mesoblast Reports First Quarter Ended September 30, 2018 Financial Results and Operational Highlights
VanadiumCorp Completes Soil Geochemical Survey at its Lac Laura Gold-Copper Property; 314 Samples Submitted to AGAT Laboratories for Analysis
New Break Drills 5.28 g/t Au over 11.2 Metres and 3.95 g/t Au over 14.0 Metres Delivering Further Strong Results at Its Moray Gold Project
